BONE BIOLOGICS CORPORATION Earnings Per Share (Diluted)
BONE BIOLOGICS CORPORATION (BBLG) reported Earnings Per Share (Diluted) of -$0.43 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-14
- BONE BIOLOGICS CORPORATION earnings per share, diluted for the quarter ending 2026-06-30 was -$0.43.
- BONE BIOLOGICS CORPORATION earnings per share, diluted for the quarter ending 2026-03-31 was -$0.43.
- BONE BIOLOGICS CORPORATION earnings per share, diluted for the quarter ending 2025-12-31 was -$0.38.
- BONE BIOLOGICS CORPORATION earnings per share, diluted for the quarter ending 2025-09-30 was -$0.37.
- BONE BIOLOGICS CORPORATION earnings per share, diluted for fiscal 2025 was -$2.65.
- BONE BIOLOGICS CORPORATION earnings per share, diluted for fiscal 2024 was -$28.96.
- BONE BIOLOGICS CORPORATION earnings per share, diluted for fiscal 2023 was -$34.01.
- BONE BIOLOGICS CORPORATION earnings per share, diluted for fiscal 2022 was -$31.15.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.43 10-Q · filed 2026-08-14 | -$0.86 10-Q · filed 2026-08-14 | -$1.24 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$1.61 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2026-03-31 | -$0.43 10-Q · filed 2026-05-14 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$1.18 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$1.92 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2025-12-31 | -$0.38 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$1.51 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$2.65 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | -$0.37 10-Q · filed 2025-11-14 | -$1.20 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.51 10-Q · filed 2025-11-14 | -$4.79 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2025-06-30 | -$1.33 10-Q · filed 2026-08-14 | -$3.23 10-Q · filed 2026-08-14 | -$6.55 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$9.41 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2025-03-31 | -$1.92 10-Q · filed 2026-05-14 | -$0.32 10-Q · filed 2025-05-12 | -$5.38 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$8.44 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$11.92 derived: net income ÷ weighted average shares · filed 2026-08-28 | |||
| 2024-12-31 | -$3.68 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$6.98 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$10.81 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$28.96 10-K · filed 2026-03-02 | -$4.83 10-K · filed 2025-02-26 | |||
| 2024-09-30 | -$14.21 10-Q · filed 2025-11-14 | -$2.37 10-Q · filed 2024-11-14 | -$7.08 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$29.09 10-Q · filed 2025-11-14 | -$4.85 10-Q · filed 2024-11-14 | -$10.31 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||
| 2024-06-30 | -$4.02 10-Q · filed 2025-08-14 | $0.67 10-Q · filed 2024-08-09 | -$10.82 10-Q · filed 2025-08-14 | -$1.80 10-Q · filed 2024-08-09 | -$7.30 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$12.00 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||
| 2024-03-31 | -$1.31 10-Q · filed 2025-05-12 | -$4.31 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$8.60 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$13.19 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2023-12-31 | -$3.38 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$8.16 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$13.21 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$34.01 10-K · filed 2025-02-26 | ||||
| 2023-09-30 | -$4.90 10-Q · filed 2024-11-14 | -$0.61 10-Q · filed 2023-11-14 | -$10.09 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$37.40 10-Q · filed 2024-11-14 | -$4.68 10-Q · filed 2023-11-14 | $565.05 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2023-06-30 | -$5.21 10-Q · filed 2024-08-09 | -$1.69 10-Q · filed 2023-08-14 | -$18.57 10-Q · filed 2024-08-09 | -$6.90 10-Q · filed 2023-08-14 | $31.42 derived: net income ÷ weighted average shares · filed 2024-11-14 | $249.98 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2023-03-31 | -$55.20 10-Q · filed 2024-05-14 | $7.25 derived: net income ÷ weighted average shares · filed 2024-11-14 | $28.01 derived: net income ÷ weighted average shares · filed 2024-11-14 | $206.71 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2022-12-31 | -$1.06 derived: net income ÷ weighted average shares · filed 2024-02-21 | $1.30 derived: net income ÷ weighted average shares · filed 2024-02-21 | $15.45 derived: net income ÷ weighted average shares · filed 2024-02-21 | -$31.15 10-K · filed 2024-02-21 | ||||
| 2022-09-30 | -$3.53 10-Q · filed 2023-11-14 | -$4.89 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$6.89 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | -$1.36 10-Q · filed 2023-08-14 | -$3.36 10-Q · filed 2023-08-14 | ||||||
| 2018-06-30 | -$0.29 10-Q · filed 2018-08-14 | -$0.62 10-Q · filed 2018-08-14 | ||||||
| 2017-06-30 | $0.25 10-Q · filed 2018-08-14 | $0.02 10-Q · filed 2017-08-08 | -$0.49 10-Q · filed 2018-08-14 | -$0.06 10-Q · filed 2017-08-08 | ||||
| 2016-06-30 | -$0.13 10-Q · filed 2017-08-08 | -$0.32 10-Q · filed 2017-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |